HTLV-1 specific CD8+ T cell function augmented by blockade of 2B4/CD48 interaction in HTLV-1 infection

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Ezinne, Chibueze Chioma ^a   Yoshimitsu, Makoto ^a,b   White, Yohann ^c   Arima, Naomichi ^a,b  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY HOSPITAL   (Japan)

^c UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

[No Author keywords available]

Indexed keywords

CD244 ANTIGEN; CD48 ANTIGEN; CD57 ANTIGEN; L SELECTIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; NATURAL KILLER CELL RECEPTOR; PERFORIN; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; CORRELATIONAL STUDY; EFFECTOR CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1 INFECTION; HUMAN T CELL LEUKEMIA VIRUS INFECTION; LIGAND BINDING; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INTERACTION; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION;

ADULT; AGED; ANTIGENS, CD; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION REGULATION; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNOLOGIC MEMORY; MALE; MIDDLE AGED; PERFORIN; RECEPTORS, IMMUNOLOGIC;

EID: 84895542408     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087631     Document Type: Article

References (48)

1. Jeffery KJ, Usuku K, Hall SE, Matsumoto W, Taylor GP, et al. (1999) HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci U S A 96: 3848-3853. (Pubitemid 29168999)
2. Furukawa Y, Yamashita M, Usuku K, Izumo S, Nakagawa M, et al. (2000) Phylogenetic subgroups of human T cell lymphotropic virus (HTLV) type I in the tax gene and their association with different risks for HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis 182: 1343-1349.
3. Osame M, Usuku K, Izumo S, Ijichi N AH et al. (1986) HTLV-1 associated myelopathy, a new clinical entity. Lancet 1: 1031-1032. (Pubitemid 16102987)
4. Uchiyama T (1988) ATLL. Blood Rev 2: 232-238.
5. Verdonck K, González E, Van Dooren S, Vandamme A-M, Vanham G, et al. (2007) Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis 7: 266-281. (Pubitemid 46414075)
6. Yoshimitsu M, White Y, Arima N (2014) Prevention of human T-cell lymphotropic virus type 1 infection and adult T-cell leukemia/lymphoma. Recent Results, Cancer Res 193: 211-215.
7. Bangham CRM, Osame M (2005) Cellular immune response to HTLV-1. Oncogene 24: 6035-6046. (Pubitemid 43086121)
8. Zajac a J, Blattman JN, Murali-Krishna K, Sourdive DJ, Suresh M, et al. (1998) Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 188: 2205-2213.
9. Virgin HW, Wherry EJ, Ahmed R (2009) Redefining chronic viral infection. Cell 138: 30-50.
10. Bangham CRM (2009) CTL quality and the control of human retroviral infections. Eur J Immunol 39: 1700-1712.
11. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, et al. (2006) Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687. (Pubitemid 43237609)
12. Wherry EJ, Ha S-J, Kaech SM, Haining WN, Sarkar S, et al. (2007) Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27: 670-684. (Pubitemid 47615511)
13. Shin H, Wherry EJ (2007) CD8 T cell dysfunction during chronic viral infection. Curr Opin Immunol 19: 408-415. (Pubitemid 47284857)
14. Day CL, Kaufmann DE, Kiepiela P, Brown J a, Moodley ES, et al. (2006) PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350-354. (Pubitemid 44435155)
15. Blackburn SD, Crawford A, Shin H, Polley A, Freeman GJ, et al. (2010) Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8 T-cell exhaustion. J Virol 84: 2078-2089.
16. Yamamoto T, Price D a, Casazza JP, Ferrari G, Nason M, et al. (2011) Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection. Blood 117: 4805-4815.
17. Urbani S, Amadei B, Tola D, Pedrazzi G, Sacchelli L, et al. (2008) Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment. J Hepatol 48: 548-558.
18. Schlaphoff V, Lunemann S, Suneetha PV, Jaroszewicz J, Grabowski J, et al. (2011) Dual function of the NK cell receptor 2B4 (CD244) in the regulation of HCV-specific CD8+ T cells. PLoS Pathog 7: e1002045.
19. Raziorrouh B, Schraut W, Gerlach T, Nowack D, Grüner NH, et al. (2010) The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function. Hepatology 52: 1934-1947.
20. Bengsch B, Seigel B, Ruhl M, Timm J, Kuntz M, et al. (2010) Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation. PLoS Pathog 6: e1000947.
21. Rey J, Giustiniani J, Mallet F, Schiavon V, Boumsell L, et al. (2006) The co-expression of 2B4 (CD244) and CD160 delineates a subpopulation of human CD8+ T cells with a potent CD160-mediated cytolytic effector function. Eur J Immunol 36: 2359-2366. (Pubitemid 44420592)
22. Nakajima H, Cella M, Langen H, Friedlein a, Colonna M (1999) Activating interactions in human NK cell recognition: the role of 2B4-CD48. Eur J Immunol 29: 1676-1683. (Pubitemid 29224473)
23. Ward J, Bonaparte M, Sacks J, Guterman J, Fogli M, et al. (2007) HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts. Blood 110: 1207-1214. (Pubitemid 47281418)
24. Klaman, L D,Thorley-Lawson AD (1995) Characterization of the CD48 Gene Demonstrates a Positive Element That Is Specific to Epstein-Barr Virus-Immortalized B-Cell Lines and Contains an Essential NF-kB Site. J Virol 69: 871-881.
25. Boles NC, Lin KK, Lukov GL, Bowman T V, Baldridge MT, et al. (2011) CD48 on hematopoietic progenitors regulates stem cells and suppresses tumor formation. 118: 80-87. doi:10.1182/blood-2010-12-322339.
26. Waggoner SN, Kumar V (2012) Evolving role of 2B4/CD244 in T and NK cell responses during virus infection. Front Immunol 3: 1-7.
27. Kozako T, Yoshimitsu M, Fujiwara H, Masamoto I, Horai S et al (2008) PD1/PDL1 expression in human T cell leukemia type 1 ACs and ATLL patients. Leukemia 23: 375-382.
28. Topalian SL, Hodi FS, Brahmer, JR Gettinger, SN Smith, DC etal (2012) Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer. 366: 2443-2454.
29. Kozako T, Arima N, Toji S, Masamoto I, Akimoto M, et al. (2006) Reduced frequency, diversity, and function of human T cell leukemia virus type 1-specific CD8+ T cell in adult T cell leukemia patients. J Immunol 177: 5718-5726. (Pubitemid 44529666)
30. Blank C, Kuball J, Voelkl S, Wiendl H, Becker B et al. (2006) Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro. Int J Cancer 119: 317-327.
31. Sabouri AH, Usuku K, Hayashi D, Izumo S, Ohara Y, et al. (2008) Impaired function of human T-lymphotropic virus type 1 (HTLV-1)-specific CD8+ T cells in HTLV-1-associated neurologic disease. Blood 112: 2411-2420.
32. Tabata Y, Villanueva J, Lee SM, Zhang K, Kanegane H, et al. (2005) Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members. Blood 105: 3066-3071.
33. Harashima N (2004) Graft-versus-Tax Response in Adult T-Cell Leukemia Patients after Hematopoietic Stem Cell Transplantation. Cancer Res 64: 391-399.
34. Kozako T, Arima N, Toji S, Masamoto I, Akimoto M, et al. (2006) Reduced frequency, diversity, and function of human T cell leukemia virus type 1-specific CD8+ T cell in adult T cell leukemia patients. J Immunol 177: 5718-5726. (Pubitemid 44529666)
35. Munitz A, Bachelet I, Levi-Schaffer F (2007) CD48 as a novel target in asthma therapy. Recent Pat Inflamm Allergy Drug Discov 1: 9-12.
36. Johnson-Nauroth JM, Graber J, Yao K, Jacobson S, Calabresi P a (2006) Memory lineage relationships in HTLV-1-specific CD8+ cytotoxic T cells. J Neuroimmunol 176: 115-124. (Pubitemid 44080326)
37. Parish IA, Kaech SM (2009) Diversity in CD8(+) T cell differentiation. Curr Opin Immunol 21: 291-297.
38. Focosi D, Bestagno M, Burrone O, Petrini M (2010) CD57 □ T lymphocytes and functional immune deficiency. 87: 107-116. doi:10.1189/jlb. 0809566.
39. West EE, Youngblood B, Tan WG, Jin H-T, Araki K, et al. (2011) Tight regulation of memory CD8(+) T cells limits their effectiveness during sustained high viral load. Immunity 35: 285-298.
40. Arnulf B, Thorel M, Poirot Y, Tamouza R, Boulanger E, et al. (2004) Loss of the ex vivo but not the reinducible CD8+ T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia/lymphoma. Leukemia, 18: 126-132. (Pubitemid 38159448)
41. Furukawa Y, Tara M, Izumo S, Arimura K, Osame M (2006) HTLV-I viral escape and host genetic changes in the development of adult T cell leukemia. Int J Cancer 118: 381-387. (Pubitemid 41782164)
42. González-Cabrero J, Wise CJ, Latchman Y, Freeman GJ, Sharpe AH, et al. (1999) CD48-deficient mice have a pronounced defect in CD4(+) T cell activation. Proc Natl Acad Sci U S A 96: 1019-1023. (Pubitemid 29072176)
43. Enose-Akahata Y, Matsuura E, Oh U, Jacobson S (2009) High expression of CD244 and SAP regulated CD8 T cell responses of patients with HTLV-I associated neurologic disease. PLoS Pathog 5: e1000682.
44. Rowan AG, Bangham CRM (2012) Is There a Role for HTLV-1-Specific CTL in Adult T-Cell Leukemia/Lymphoma? Leuk Res Treatment 2012: 391953.
45. Kattan T, MacNamara A, Rowan AG, Nose H, Mosley AJ, et al. (2009) The avidity and lytic efficiency of the CTL response to HTLV-1. J Immunol 182: 5723-5729.
46. Sabouri AH, Saito M, Usuku K, Bajestan SN, Mahmoudi M, et al. (2005) Differences in viral and host genetic risk factors for development of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis between Iranian and Japanese HTLV-1-infected individuals. J Gen Virol 86: 773-781. (Pubitemid 40331258)
47. Radoja S, Saio M, Schaer D, Koneru M, Vukmanovic S, et al. (2001) CD8+ Tumor-Infiltrating T Cells Are Deficient in Perforin-Mediated Cytolytic Activity Due to Defective Microtubule-Organizing Center Mobilization and Lytic Granule Exocytosis. J Immunol 167: 5042-5051. (Pubitemid 33009737)
48. Takamori A, Hasegawa A, Utsunomiya A, Maeda Y, Yamano Y, et al. (2011) Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers. Retrovirology 8: 100.